Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CD45RB MAb prolongs allograft survival in mice

Aug. 28, 2002

IL-10 gene therapy prevents recurrence of autoimmune diabetes after islet transplantation

Aug. 28, 2002

5-ASA-containing prodrugs for IBD presented at ACS

Aug. 27, 2002

Compounds with potent and selective caspase-3 inhibitory activity disclosed by Merck Frosst

Aug. 27, 2002

TACE inhibitors presented by Bristol-Myers Squibb at ACS

Aug. 27, 2002

Synthesis and SAR of new series of CRH1 antagonists reported in Boston

Aug. 27, 2002

Novel GABA-A/BDZ modulators presented by Neurogen and Lilly at ACS meeting

Aug. 27, 2002

New 5-HT2C agonist and its use in erectile dysfunction discussed at ACS meeting

Aug. 23, 2002

In vitro and in vivo studies on bone-healing agent CP-533536 reported at ACS

Aug. 23, 2002

Novel nonprostanoid EP4 antagonist prepared and tested at GSK

Aug. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...